Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Toxins (Basel) ; 12(6)2020 06 04.
Artigo em Inglês | MEDLINE | ID: mdl-32512716

RESUMO

Pseudomonas aeruginosa is an opportunistic pathogen that causes pneumonia in immunocompromised and intensive care unit (ICU) patients. During host infection, P. aeruginosa upregulates the type III secretion system (T3SS), which is used to intoxicate host cells with exoenzyme (Exo) virulence factors. Of the four known Exo virulence factors (U, S, T and Y), ExoU has been shown in prior studies to associate with high mortality rates. Preclinical studies have shown that ExoY is an important edema factor in lung infection caused by P. aeruginosa, although its importance in clinical isolates of P. aeruginosa is unknown. We hypothesized that expression of ExoY would be highly prevalent in clinical isolates and would significantly contribute to patient morbidity secondary to P. aeruginosa pneumonia. A single-center, prospective observational study was conducted at the University of Alabama at Birmingham Hospital. Mechanically ventilated ICU patients with a bronchoalveolar lavage fluid culture positive for P. aeruginosa were included. Enrolled patients were followed from ICU admission to discharge and clinical P. aeruginosa isolates were genotyped for the presence of exoenzyme genes. Ninety-nine patients were enrolled in the study. ExoY was present in 93% of P. aeruginosa clinical isolates. Moreover, ExoY alone (ExoY+/ExoU-) was present in 75% of P. aeruginosa isolates, compared to 2% ExoU alone (ExoY-/ExoU+). We found that bacteria isolated from human samples expressed active ExoY and ExoU, and the presence of ExoY in clinical isolates was associated with end-organ dysfunction. This is the first study we are aware of that demonstrates that ExoY is important in clinical outcomes secondary to nosocomial pneumonia.


Assuntos
Proteínas de Bactérias/metabolismo , Toxinas Bacterianas/metabolismo , Infecção Hospitalar/microbiologia , Glucosiltransferases/metabolismo , Insuficiência de Múltiplos Órgãos/microbiologia , Pneumonia Bacteriana/microbiologia , Infecções por Pseudomonas/microbiologia , Pseudomonas aeruginosa/enzimologia , Fatores de Virulência/metabolismo , Animais , Proteínas de Bactérias/genética , Toxinas Bacterianas/genética , Células Cultivadas , Estado Terminal , Infecção Hospitalar/diagnóstico , Infecção Hospitalar/mortalidade , Feminino , Glucosiltransferases/genética , Humanos , Masculino , Pessoa de Meia-Idade , Insuficiência de Múltiplos Órgãos/diagnóstico , Insuficiência de Múltiplos Órgãos/mortalidade , Pneumonia Bacteriana/diagnóstico , Pneumonia Bacteriana/mortalidade , Estudos Prospectivos , Infecções por Pseudomonas/diagnóstico , Infecções por Pseudomonas/mortalidade , Pseudomonas aeruginosa/genética , Pseudomonas aeruginosa/patogenicidade , Ratos , Respiração Artificial/efeitos adversos , Fatores de Risco , Virulência , Fatores de Virulência/genética
2.
Am J Respir Cell Mol Biol ; 63(2): 234-243, 2020 08.
Artigo em Inglês | MEDLINE | ID: mdl-32243761

RESUMO

Pseudomonas aeruginosa is a lethal pathogen that causes high mortality and morbidity in immunocompromised and critically ill patients. The type III secretion system (T3SS) of P. aeruginosa mediates many of the adverse effects of infection with this pathogen, including increased lung permeability in a Toll-like receptor 4/RhoA/PAI-1 (plasminogen activator inhibitor-1)-dependent manner. α-Tocopherol has antiinflammatory properties that may make it a useful adjunct in treatment of this moribund infection. We measured transendothelial and transepithelial resistance, RhoA and PAI-1 activation, stress fiber formation, P. aeruginosa T3SS exoenzyme (ExoY) intoxication into host cells, and survival in a murine model of pneumonia in the presence of P. aeruginosa and pretreatment with α-tocopherol. We found that α-tocopherol alleviated P. aeruginosa-mediated alveolar endothelial and epithelial paracellular permeability by inhibiting RhoA, in part, via PAI-1 activation, and increased survival in a mouse model of P. aeruginosa pneumonia. Furthermore, we found that α-tocopherol decreased the activation of RhoA and PAI-1 by blocking the injection of T3SS exoenzymes into alveolar epithelial cells. P. aeruginosa is becoming increasingly antibiotic resistant. We provide evidence that α-tocopherol could be a useful therapeutic agent for individuals who are susceptible to infection with P. aeruginosa, such as those who are immunocompromised or critically ill.


Assuntos
Pneumonia/tratamento farmacológico , Infecções por Pseudomonas/tratamento farmacológico , Pseudomonas aeruginosa/efeitos dos fármacos , alfa-Tocoferol/farmacologia , Animais , Proteínas de Bactérias/metabolismo , Células Cultivadas , Modelos Animais de Doenças , Endotélio/efeitos dos fármacos , Endotélio/metabolismo , Humanos , Pulmão , Camundongos , Camundongos Endogâmicos C57BL , Inibidor 1 de Ativador de Plasminogênio/metabolismo , Pseudomonas aeruginosa/metabolismo , Ratos , Sistemas de Secreção Tipo III/efeitos dos fármacos , Proteína rhoA de Ligação ao GTP/metabolismo
3.
FASEB J ; 30(7): 2557-69, 2016 07.
Artigo em Inglês | MEDLINE | ID: mdl-27025963

RESUMO

TGF-ß1 induces an increase in paracellular permeability and actin stress fiber formation in lung microvascular endothelial and alveolar epithelial cells via small Rho GTPase. The molecular mechanism involved is not fully understood. Neuronal Wiskott-Aldrich syndrome protein (N-WASP) has an essential role in actin structure dynamics. We hypothesized that N-WASP plays a critical role in these TGF-ß1-induced responses. In these cell monolayers, we demonstrated that N-WASP down-regulation by short hairpin RNA prevented TGF-ß1-mediated disruption of the cortical actin structure, actin stress filament formation, and increased permeability. Furthermore, N-WASP down-regulation blocked TGF-ß1 activation mediated by IL-1ß in alveolar epithelial cells, which requires actin stress fiber formation. Control short hairpin RNA had no effect on these TGF-ß1-induced responses. TGF-ß1-induced phosphorylation of Y256 of N-WASP via activation of small Rho GTPase and focal adhesion kinase mediates TGF-ß1-induced paracellular permeability and actin cytoskeleton dynamics. In vivo, compared with controls, N-WASP down-regulation increases survival and prevents lung edema in mice induced by bleomycin exposure-a lung injury model in which TGF-ß1 plays a critical role. Our data indicate that N-WASP plays a crucial role in the development of TGF-ß1-mediated acute lung injury by promoting pulmonary edema via regulation of actin cytoskeleton dynamics.-Wagener, B. M., Hu, M., Zheng, A., Zhao, X., Che, P., Brandon, A., Anjum, N., Snapper, S., Creighton, J., Guan, J.-L., Han, Q., Cai, G.-Q., Han, X., Pittet, J.-F., Ding, Q. Neuronal Wiskott-Aldrich syndrome protein regulates TGF-ß1-mediated lung vascular permeability.


Assuntos
Permeabilidade Capilar/fisiologia , Células Endoteliais/fisiologia , Pulmão/irrigação sanguínea , Fator de Crescimento Transformador beta1/metabolismo , Proteína Neuronal da Síndrome de Wiskott-Aldrich/metabolismo , Animais , Bleomicina/toxicidade , Células Cultivadas , Regulação da Expressão Gênica/fisiologia , Lesão Pulmonar/induzido quimicamente , Camundongos , Neurônios , Ratos , Fator de Crescimento Transformador beta1/genética , Proteína Neuronal da Síndrome de Wiskott-Aldrich/genética
4.
Anesthesiology ; 120(6): 1450-62, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24667831

RESUMO

BACKGROUND: The heat-shock response (HSR) protects from insults, such as ischemia-reperfusion injury, by inhibiting signaling pathways activated by sterile inflammation. However, the mechanisms by which the HSR activation would modulate lung damage and host response to a bacterial lung infection remain unknown. METHODS: HSR was activated with whole-body hyperthermia or by intraperitoneal geldanamycin in mice that had their lungs instilled with Pseudomonas aeruginosa 24 h later (at least six mice per experimental group). Four hours after instillation, lung endothelial and epithelial permeability, bacterial counts, protein levels in bronchoalveolar lavage fluid, and lung myeloperoxidase activity were measured. Mortality rate 24 h after P. aeruginosa instillation was recorded. The HSR effect on the release of interleukin-10 and killing of P. aeruginosa bacteria by a mouse alveolar macrophage cell line and on neutrophil phagocytosis was also examined. RESULTS: HSR activation worsened lung endothelial (42%) and epithelial permeability (50%) to protein, decreased lung bacterial clearance (71%), and increased mortality (50%) associated with P. aeruginosa pneumonia, an effect that was not observed in heat-shock protein-72-null mice. HSR-mediated decrease in neutrophil phagocytosis (69%) and bacterial killing (38%) by macrophages was interleukin-10 dependent, a mechanism confirmed by increased lung bacterial clearance and decreased mortality (70%) caused by P. aeruginosa pneumonia in heat-shocked interleukin-10-null mice. CONCLUSIONS: Prior HSR activation worsens lung injury associated with P. aeruginosa pneumonia in mice via heat-shock protein-72- and interleukin-10-dependent mechanisms. These results provide a novel mechanism for the immunosuppression observed after severe trauma that is known to activate HSR in humans.


Assuntos
Proteínas de Choque Térmico HSP72/fisiologia , Interleucina-10/fisiologia , Lesão Pulmonar/metabolismo , Infecções por Pseudomonas/metabolismo , Pseudomonas aeruginosa , Regulação para Cima/imunologia , Animais , Linhagem Celular , Células Cultivadas , Resposta ao Choque Térmico/imunologia , Interleucina-10/metabolismo , Lesão Pulmonar/imunologia , Lesão Pulmonar/microbiologia , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Infecções por Pseudomonas/imunologia , Distribuição Aleatória , Ovinos
5.
Shock ; 39(2): 189-96, 2013 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-23324889

RESUMO

Acute lung injury (ALI) is a clinical syndrome characterized by hypoxia, which is caused by the breakdown of the alveolar capillary barrier. Interleukin 1ß (IL-1ß), a cytokine released within the airspace in ALI, downregulates the α subunit of the epithelial sodium channel (αENaC) transcription and protein expression via p38 MAP kinase-dependent signaling. Although induction of the heat shock response can restore alveolar fluid clearance compromised by IL-1ß following the onset of severe hemorrhagic shock in rats, the mechanisms are not fully understood. In this study, we report that the induction of the heat shock response prevents IL-1ß-dependent inhibition of αENaC mRNA expression and subsequent channel function. Heat shock results in IRAK1 detergent insolubility and a disruption of Hsp90 binding to IRAK1. Likewise, TAK1, another client protein of Hsp90 and signaling component of the IL-1ß pathway, is also detergent insoluble after heat shock. Twenty-four hours after heat shock, both IRAK1 and TAK1 are again detergent soluble, which correlates with the IL-1ß-dependent p38 activation. Remarkably, IL-1ß-dependent p38 activation 24 h after heat shock did not result in an inhibition of αENaC mRNA expression and channel function. Further analysis demonstrates prolonged preservation of αENaC expression by the activation of the heat shock response that involves inducible Hsp70. Inhibition of Hsp70 at 24 h after heat shock results in p38-dependent IL-1ß inhibition of αENaC mRNA expression, whereas overexpression of Hsp70 attenuates the p38-dependent IL-1ß inhibition of αENaC mRNA expression. These studies demonstrate new mechanisms by which the induction of the heat shock response protects the barrier function of the alveolar epithelium in ALI.


Assuntos
Lesão Pulmonar Aguda/prevenção & controle , Amilorida/farmacologia , Bloqueadores do Canal de Sódio Epitelial/farmacologia , Resposta ao Choque Térmico/fisiologia , Interleucina-1beta/fisiologia , Alvéolos Pulmonares/metabolismo , Animais , Benzoquinonas/farmacologia , Proteínas do Citoesqueleto/farmacologia , Proteínas de Ligação a DNA/farmacologia , Canais Epiteliais de Sódio/efeitos dos fármacos , Proteínas de Choque Térmico HSP70/metabolismo , Quinases Associadas a Receptores de Interleucina-1/metabolismo , Proteínas com Domínio LIM/farmacologia , Lactamas Macrocíclicas/farmacologia , MAP Quinase Quinase Quinases/metabolismo , Sistema de Sinalização das MAP Quinases/fisiologia , Masculino , RNA Mensageiro/metabolismo , Ratos , Mucosa Respiratória/metabolismo , Regulação para Cima
6.
FASEB J ; 26(7): 2919-29, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22490926

RESUMO

Infectious complications, predominantly pneumonia, are the most common cause of death in the postacute phase of stroke, although the mechanisms underlying the corresponding immunosuppression are not fully understood. We tested the hypothesis that activation of the α7 nicotinic acetylcholine receptor (α7nAChR) pathway is important in the stroke-induced increase in lung injury caused by Pseudomonas aeruginosa pneumonia in mice. Prior stroke increased lung vascular permeability caused by P. aeruginosa pneumonia and was associated with decreased lung neutrophil recruitment and bacterial clearance in mice. Pharmacologic inhibition (methyllycaconitine IC(50): 0.2-0.6 nM) or genetic deletion of the α7nAChR significantly (P<0.05) attenuates the effect of prior stroke on lung injury and mortality caused by P. aeruginosa pneumonia in mice. Finally, pretreatment with PNU-282987, a pharmacologic activator of the α7nAChR (EC(50): 0.2 µM), significantly (P<0.05) increased lung injury caused by P. aeruginosa pneumonia, significantly (P<0.05) decreased the release of KC, a major neutrophil chemokine, and significantly (P<0.05) decreased intracellular bacterial killing by a mouse alveolar macrophage cell line and primary mouse neutrophils. In summary, the α7 nicotinic cholinergic pathway plays an important role in mediating the systemic immunosuppression observed after stroke and directly contributes to more severe lung damage induced by P. aeruginosa.


Assuntos
Infarto da Artéria Cerebral Média/complicações , Infarto da Artéria Cerebral Média/metabolismo , Pneumonia Bacteriana/etiologia , Pneumonia Bacteriana/metabolismo , Infecções por Pseudomonas/etiologia , Infecções por Pseudomonas/metabolismo , Pseudomonas aeruginosa , Receptores Nicotínicos/metabolismo , Aconitina/análogos & derivados , Aconitina/farmacologia , Antagonistas Adrenérgicos beta/farmacologia , Animais , Benzamidas/farmacologia , Compostos Bicíclicos com Pontes/farmacologia , Linhagem Celular , Modelos Animais de Doenças , Tolerância Imunológica , Infarto da Artéria Cerebral Média/imunologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Neutrófilos/imunologia , Agonistas Nicotínicos/farmacologia , Antagonistas Nicotínicos/farmacologia , Pneumonia Bacteriana/imunologia , Infecções por Pseudomonas/imunologia , Pseudomonas aeruginosa/imunologia , Edema Pulmonar/etiologia , Receptores Nicotínicos/deficiência , Receptores Nicotínicos/genética , Transdução de Sinais , Receptor Nicotínico de Acetilcolina alfa7
7.
Exp Neurol ; 206(1): 95-100, 2007 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-17509567

RESUMO

Peri-infarct increase of vascular density has been observed in animals and in humans with ischemic stroke. Increased peri-infarct vascular density correlates with improved functional outcome after stroke. We hypothesized that pre-treatment with estradiol will increase post-ischemic peri-infarct capillary density in a rat model of transient ischemic stroke. Estradiol, compared to placebo, augmented post-ischemic peri-infarct vascular density by 22% 10 days after stroke. Recovery of forelimb function was not improved with estradiol treatment on day three and nine post-stroke. Loss of estradiol may limit repair in the peri-infarct region by limiting angiogenesis, but functional significance in stroke recovery requires further investigation.


Assuntos
Indutores da Angiogênese/farmacologia , Infarto Encefálico/tratamento farmacológico , Artérias Cerebrais/efeitos dos fármacos , Estradiol/farmacologia , Neovascularização Fisiológica/efeitos dos fármacos , Acidente Vascular Cerebral/tratamento farmacológico , Indutores da Angiogênese/uso terapêutico , Animais , Infarto Encefálico/fisiopatologia , Capilares/efeitos dos fármacos , Capilares/fisiologia , Artérias Cerebrais/fisiopatologia , Modelos Animais de Doenças , Estradiol/uso terapêutico , Feminino , Membro Anterior/inervação , Membro Anterior/fisiopatologia , Microcirculação/efeitos dos fármacos , Microcirculação/fisiologia , Córtex Motor/irrigação sanguínea , Córtex Motor/efeitos dos fármacos , Córtex Motor/fisiopatologia , Neovascularização Fisiológica/fisiologia , Paresia/tratamento farmacológico , Paresia/etiologia , Paresia/fisiopatologia , Ratos , Ratos Wistar , Recuperação de Função Fisiológica/efeitos dos fármacos , Recuperação de Função Fisiológica/fisiologia , Acidente Vascular Cerebral/fisiopatologia , Telencéfalo/irrigação sanguínea , Telencéfalo/efeitos dos fármacos , Telencéfalo/fisiopatologia , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...